PMC5193135

Higher lactation intensity at 6-9 weeks postpartum was independently associated with lower 2-year incidence of type 2 diabetes after gestational diabetes pregnancy in a graded dose-response manner, wi

Effect: improvement; HR 0.46; CI: 95% CI 0.29-0.71

Higher lactation intensity at 6-9 weeks postpartum was independently associated with lower 2-year incidence of type 2 diabetes after gestational diabetes pregnancy in a graded dose-response manner, wi

Effect: improvement; HR 0.46; CI: 95% CI 0.29-0.71

Higher lactation intensity at 6-9 weeks postpartum was independently associated with lower 2-year incidence of type 2 diabetes after gestational diabetes pregnancy in a graded dose-response manner, wi

Effect: improvement; HR 0.46; CI: 95% CI 0.29-0.71

Higher lactation intensity at 6-9 weeks postpartum was independently associated with lower 2-year incidence of type 2 diabetes after gestational diabetes pregnancy in a graded dose-response manner, wi

Effect: improvement; HR 0.46; CI: 95% CI 0.29-0.71

Higher lactation intensity at 6-9 weeks postpartum was independently associated with lower 2-year incidence of type 2 diabetes after gestational diabetes pregnancy in a graded dose-response manner, wi

Effect: improvement; HR 0.46; CI: 95% CI 0.29-0.71

Higher lactation intensity at 6-9 weeks postpartum was independently associated with lower 2-year incidence of type 2 diabetes after gestational diabetes pregnancy in a graded dose-response manner, wi

Effect: improvement; HR 0.46; CI: 95% CI 0.29-0.71

Higher lactation intensity at 6-9 weeks postpartum was independently associated with lower 2-year incidence of type 2 diabetes after gestational diabetes pregnancy in a graded dose-response manner, wi

Effect: improvement; HR 0.46; CI: 95% CI 0.29-0.71

Higher lactation intensity at 6-9 weeks postpartum was independently associated with lower 2-year incidence of type 2 diabetes after gestational diabetes pregnancy in a graded dose-response manner, wi

Effect: improvement; HR 0.46; CI: 95% CI 0.29-0.71

Higher lactation intensity at 6-9 weeks postpartum was independently associated with lower 2-year incidence of type 2 diabetes after gestational diabetes pregnancy in a graded dose-response manner, wi

Effect: improvement; HR 0.46; CI: 95% CI 0.29-0.71

Higher lactation intensity at 6-9 weeks postpartum was independently associated with lower 2-year incidence of type 2 diabetes after gestational diabetes pregnancy in a graded dose-response manner, wi

Effect: improvement; HR 0.46; CI: 95% CI 0.29-0.71

Higher lactation intensity at 6-9 weeks postpartum was independently associated with lower 2-year incidence of type 2 diabetes after gestational diabetes pregnancy in a graded dose-response manner, wi

Effect: improvement; HR 0.46; CI: 95% CI 0.29-0.71

Higher lactation intensity at 6-9 weeks postpartum was independently associated with lower 2-year incidence of type 2 diabetes after gestational diabetes pregnancy in a graded dose-response manner, wi

Effect: improvement; HR 0.46; CI: 95% CI 0.29-0.71

Higher lactation intensity at 6-9 weeks postpartum was independently associated with lower 2-year incidence of type 2 diabetes after gestational diabetes pregnancy in a graded dose-response manner, wi

Effect: improvement; HR 0.46; CI: 95% CI 0.29-0.71

Higher lactation intensity at 6-9 weeks postpartum was independently associated with lower 2-year incidence of type 2 diabetes after gestational diabetes pregnancy in a graded dose-response manner, wi

Effect: improvement; HR 0.46; CI: 95% CI 0.29-0.71

Higher lactation intensity at 6-9 weeks postpartum was independently associated with lower 2-year incidence of type 2 diabetes after gestational diabetes pregnancy in a graded dose-response manner, wi

Effect: improvement; HR 0.46; CI: 95% CI 0.29-0.71

Higher lactation intensity at 6-9 weeks postpartum was independently associated with lower 2-year incidence of type 2 diabetes after gestational diabetes pregnancy in a graded dose-response manner, wi

Effect: improvement; HR 0.46; CI: 95% CI 0.29-0.71

Higher lactation intensity at 6-9 weeks postpartum was independently associated with lower 2-year incidence of type 2 diabetes after gestational diabetes pregnancy in a graded dose-response manner, wi

Effect: improvement; HR 0.46; CI: 95% CI 0.29-0.71

Higher lactation intensity at 6-9 weeks postpartum was independently associated with lower 2-year incidence of type 2 diabetes after gestational diabetes pregnancy in a graded dose-response manner, wi

Effect: improvement; HR 0.46; CI: 95% CI 0.29-0.71

Higher lactation intensity at 6-9 weeks postpartum was independently associated with lower 2-year incidence of type 2 diabetes after gestational diabetes pregnancy in a graded dose-response manner, wi

Effect: improvement; HR 0.46; CI: 95% CI 0.29-0.71

Higher lactation intensity at 6-9 weeks postpartum was independently associated with lower 2-year incidence of type 2 diabetes after gestational diabetes pregnancy in a graded dose-response manner, wi

Effect: improvement; HR 0.46; CI: 95% CI 0.29-0.71

Higher lactation intensity at 6-9 weeks postpartum was independently associated with lower 2-year incidence of type 2 diabetes after gestational diabetes pregnancy in a graded dose-response manner, wi

Effect: improvement; HR 0.46; CI: 95% CI 0.29-0.71

Higher lactation intensity at 6-9 weeks postpartum was independently associated with lower 2-year incidence of type 2 diabetes after gestational diabetes pregnancy in a graded dose-response manner, wi

Effect: improvement; HR 0.46; CI: 95% CI 0.29-0.71

Higher lactation intensity at 6-9 weeks postpartum was independently associated with lower 2-year incidence of type 2 diabetes after gestational diabetes pregnancy in a graded dose-response manner, wi

Effect: improvement; HR 0.46; CI: 95% CI 0.29-0.71

Higher lactation intensity at 6-9 weeks postpartum was independently associated with lower 2-year incidence of type 2 diabetes after gestational diabetes pregnancy in a graded dose-response manner, wi

Effect: improvement; HR 0.46; CI: 95% CI 0.29-0.71

Higher lactation intensity at 6-9 weeks postpartum was independently associated with lower 2-year incidence of type 2 diabetes after gestational diabetes pregnancy in a graded dose-response manner, wi

Effect: improvement; HR 0.46; CI: 95% CI 0.29-0.71

Higher lactation intensity at 6-9 weeks postpartum was independently associated with lower 2-year incidence of type 2 diabetes after gestational diabetes pregnancy in a graded dose-response manner, wi

Effect: improvement; HR 0.46; CI: 95% CI 0.29-0.71

Higher lactation intensity at 6-9 weeks postpartum was independently associated with lower 2-year incidence of type 2 diabetes after gestational diabetes pregnancy in a graded dose-response manner, wi

Effect: improvement; HR 0.46; CI: 95% CI 0.29-0.71

Longer duration of lactation was independently associated with lower 2-year incidence of type 2 diabetes after gestational diabetes pregnancy in a graded dose-response manner, with >10 months of breas

Effect: improvement; HR 0.43; CI: 95% CI 0.22-0.82

Longer duration of lactation was independently associated with lower 2-year incidence of type 2 diabetes after gestational diabetes pregnancy in a graded dose-response manner, with >10 months of breas

Effect: improvement; HR 0.43; CI: 95% CI 0.22-0.82

Longer duration of lactation was independently associated with lower 2-year incidence of type 2 diabetes after gestational diabetes pregnancy in a graded dose-response manner, with >10 months of breas

Effect: improvement; HR 0.43; CI: 95% CI 0.22-0.82

Longer duration of lactation was independently associated with lower 2-year incidence of type 2 diabetes after gestational diabetes pregnancy in a graded dose-response manner, with >10 months of breas

Effect: improvement; HR 0.43; CI: 95% CI 0.22-0.82

Longer duration of lactation was independently associated with lower 2-year incidence of type 2 diabetes after gestational diabetes pregnancy in a graded dose-response manner, with >10 months of breas

Effect: improvement; HR 0.43; CI: 95% CI 0.22-0.82

Longer duration of lactation was independently associated with lower 2-year incidence of type 2 diabetes after gestational diabetes pregnancy in a graded dose-response manner, with >10 months of breas

Effect: improvement; HR 0.43; CI: 95% CI 0.22-0.82

Longer duration of lactation was independently associated with lower 2-year incidence of type 2 diabetes after gestational diabetes pregnancy in a graded dose-response manner, with >10 months of breas

Effect: improvement; HR 0.43; CI: 95% CI 0.22-0.82

Longer duration of lactation was independently associated with lower 2-year incidence of type 2 diabetes after gestational diabetes pregnancy in a graded dose-response manner, with >10 months of breas

Effect: improvement; HR 0.43; CI: 95% CI 0.22-0.82

Longer duration of lactation was independently associated with lower 2-year incidence of type 2 diabetes after gestational diabetes pregnancy in a graded dose-response manner, with >10 months of breas

Effect: improvement; HR 0.43; CI: 95% CI 0.22-0.82

Longer duration of lactation was independently associated with lower 2-year incidence of type 2 diabetes after gestational diabetes pregnancy in a graded dose-response manner, with >10 months of breas

Effect: improvement; HR 0.43; CI: 95% CI 0.22-0.82

Longer duration of lactation was independently associated with lower 2-year incidence of type 2 diabetes after gestational diabetes pregnancy in a graded dose-response manner, with >10 months of breas

Effect: improvement; HR 0.43; CI: 95% CI 0.22-0.82

Longer duration of lactation was independently associated with lower 2-year incidence of type 2 diabetes after gestational diabetes pregnancy in a graded dose-response manner, with >10 months of breas

Effect: improvement; HR 0.43; CI: 95% CI 0.22-0.82

Longer duration of lactation was independently associated with lower 2-year incidence of type 2 diabetes after gestational diabetes pregnancy in a graded dose-response manner, with >10 months of breas

Effect: improvement; HR 0.43; CI: 95% CI 0.22-0.82

Longer duration of lactation was independently associated with lower 2-year incidence of type 2 diabetes after gestational diabetes pregnancy in a graded dose-response manner, with >10 months of breas

Effect: improvement; HR 0.43; CI: 95% CI 0.22-0.82

Longer duration of lactation was independently associated with lower 2-year incidence of type 2 diabetes after gestational diabetes pregnancy in a graded dose-response manner, with >10 months of breas

Effect: improvement; HR 0.43; CI: 95% CI 0.22-0.82

Longer duration of lactation was independently associated with lower 2-year incidence of type 2 diabetes after gestational diabetes pregnancy in a graded dose-response manner, with >10 months of breas

Effect: improvement; HR 0.43; CI: 95% CI 0.22-0.82

Longer duration of lactation was independently associated with lower 2-year incidence of type 2 diabetes after gestational diabetes pregnancy in a graded dose-response manner, with >10 months of breas

Effect: improvement; HR 0.43; CI: 95% CI 0.22-0.82

Longer duration of lactation was independently associated with lower 2-year incidence of type 2 diabetes after gestational diabetes pregnancy in a graded dose-response manner, with >10 months of breas

Effect: improvement; HR 0.43; CI: 95% CI 0.22-0.82

Longer duration of lactation was independently associated with lower 2-year incidence of type 2 diabetes after gestational diabetes pregnancy in a graded dose-response manner, with >10 months of breas

Effect: improvement; HR 0.43; CI: 95% CI 0.22-0.82

Longer duration of lactation was independently associated with lower 2-year incidence of type 2 diabetes after gestational diabetes pregnancy in a graded dose-response manner, with >10 months of breas

Effect: improvement; HR 0.43; CI: 95% CI 0.22-0.82

Longer duration of lactation was independently associated with lower 2-year incidence of type 2 diabetes after gestational diabetes pregnancy in a graded dose-response manner, with >10 months of breas

Effect: improvement; HR 0.43; CI: 95% CI 0.22-0.82

Longer duration of lactation was independently associated with lower 2-year incidence of type 2 diabetes after gestational diabetes pregnancy in a graded dose-response manner, with >10 months of breas

Effect: improvement; HR 0.43; CI: 95% CI 0.22-0.82

Longer duration of lactation was independently associated with lower 2-year incidence of type 2 diabetes after gestational diabetes pregnancy in a graded dose-response manner, with >10 months of breas

Effect: improvement; HR 0.43; CI: 95% CI 0.22-0.82